tm logo
KINNATE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 18 Mar 2024

Last Applicant/ Owned by

103 Montgomery Street, Suite 150

San Francisco

CA

94129

Serial Number

90127831 filed on 20th Aug 2020

Registration Number

N/A

Correspondent Address

Kinnate Biopharma Inc.

103 Montgomery Street, Suite 150

San Francisco,CA 94129

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KINNATE

scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development therapeuticRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development

Class [005]
Pharmaceutical Products


therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies

Mark Details


Serial Number

No 90127831

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Mar 2024ABANDONMENT - NO USE STATEMENT FILED
18th Mar 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06th Feb 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06th Feb 2024WITHDRAWAL OF ATTORNEY GRANTED
01st Jun 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30th May 2023SOU TEAS EXTENSION RECEIVED
30th May 2023SOU EXTENSION 3 FILED
30th May 2023SOU EXTENSION 3 GRANTED
20th Dec 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Dec 2022SOU TEAS EXTENSION RECEIVED